SCHEDULE 13G

Company

BioLineRx Ltd.

Filed

February 7, 2012

Accession Number

0001019056-12-000122

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →